title: Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.
abstract: OBJECTIVE
  To report the favorable outcome of a patient with severe ocular cicatricial pemphigoid, which was refractory to conventional treatment but recovered after intravenous immunoglobulin therapy.
  
  
  METHODS
  A case report.
  
  
  RESULTS
  Conventional therapy failed to control the ocular symptoms of this patient, which are typical of the disease. However, the patient improved remarkably in response to pulsed intravenous human immunoglobulin therapy.
  
  
  CONCLUSIONS
  We achieved stabilization of the disease around the seventh intravenous immunoglobulin cycle, thus contributing to satisfactory postoperative evolution after limbal allograft transplantation and facilitating the performance of intraocular surgical procedures, such as phacoemulsification, with improvement in best-corrected visual acuity.
authors: Department of Ophthalmology, Cornea & External Diseases Service, Cruces Hospital, Baracaldo, Vizcaya, Spain. martagaldos@monteurquiola.com
authors: Marta
authors: M
authors: Galdos
authors: Jaime
authors: J
authors: Etxebarría
mesh_terms: D000368:Aged; D003231:Conjunctivitis / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D010390:Pemphigoid, Benign Mucous Membrane / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors